DGAP-News: Neovacs S.A. / Key word(s): Miscellaneous Neovacs S.A.: 2015 Financial Calendar 26.01.2015 / 18:30 --------------------------------------------------------------------- PRESS RELEASE 2015 Financial Calendar Paris, January 26, 2015 - NEOVACS (Alternext Paris : ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, annonced today its financial reporting calendar for 2015. Financial publications will be released prior to the opening of the Paris stock exchange. This calendar is indicative and subject to change. - 2014 Full-Year results: February 27, 2015 - Shareholders' AGM: April 8, 2015 - 2015 Half-Year results: September 4, 2015 About Neovacs Created in 1993, Neovacs is today a leading biotechnology company focused on an active immunotherapy technology platform (Kinoids) with applications in autoimmune and/or inflammatory diseases. On the basis of the company's proprietary technology for inducing a polyclonal immune response (covered by five patent families that potentially run until 2032) Neovacs is focusing its clinical development efforts on IFNα-Kinoid, an immunotherapy being developed for the indication of lupus. Neovacs is also conducting preclinical development works on other therapeutic vaccines in the fields of auto-immune diseases, oncology and allergies. The goal of the Kinoid approach is to enable patients to have access to safe treatments with efficacy that is sustained in these life-long diseases. For more information on Neovacs, visit www.neovacs.fr Contacts Neovacs Nathalie Trépo +33 (0)1 53 10 93 00 ntrepo@neovacs.com Investor Relations - Financial Communications Germany - MC Services Raimund Gabriel +49-89-210228-30 raimund.gabriel@mc-services.eu Press - U.S. Inquiries - The Ruth Group Melanie Sollid-Penton 1.646.536.7023 msollid@theruthgroup.com --------------------------------------------------------------------- 26.01.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Neovacs S.A. 3-5, Impasse Reille 75014 Paris France Phone: +33 (0)1 53 10 93 00 Fax: +33 (0)1 53 10 93 03 E-mail: www.neovacs.fr Internet: info@neovacs.fr ISIN: FR0004032746 WKN: A1CVKR Listed: Freiverkehr in Stuttgart; Frankfurt in Open Market End of News DGAP News-Service --------------------------------------------------------------------- 316457 26.01.2015
DGAP-News: Neovacs S.A.: 2015 Financial Calendar
| Source: EQS Group AG